LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceuticals, Inc. ("ARS" or "the Company") (NASDAQ:SPRY) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or […]
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Xometry, Inc. ("Xometry" or "the Company") (NASDAQ:XMTR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of P10, Inc. ("P10" or "the Company") (NYSE:PX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Duke Realty ("Duke" or "the Company") (NYSE:DRE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Physicians Realty Trust ("Physicians Realty Trust" or "the Company") (NYSE:DOC) for violations of the securities laws. The investigation focuses on whether the Company issued
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Bank OZK ("Bank OZK" or "the Company") (NASDAQ:OZK) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics" or "the Company") (NASDAQ:FDMT) for violations of the securities laws. The investigation focuses on whether the Company
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Rapid7, Inc. ("Rapid7" or "the Company") (NASDAQ:RPD) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Thoughtworks Holding, Inc. ("Thoughtworks" or "the Company") (NASDAQ:TWKS) for potential breaches of fiduciary duty on the part of its directors and management. The investigation
LOS ANGELES, CA / ACCESSWIRE / October 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Wolfspeed, Inc. ("Wolfspeed" or "the Company") (NYSE:WOLF) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading